{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:55:58Z","timestamp":1772585758945,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Chengdu Medical College","award":["CYZ18-20"],"award-info":[{"award-number":["CYZ18-20"]}]},{"name":"the Education and Teaching Reform Project of Chengdu Medical College","award":["JG202007"],"award-info":[{"award-number":["JG202007"]}]},{"name":"the Graduate Student Innovation Project of Chengdu Medical College","award":["YCX2022-01-10"],"award-info":[{"award-number":["YCX2022-01-10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04684-0","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T05:53:45Z","timestamp":1770098025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Untargeted red blood cell metabolomics reveals distinct metabolic signatures in malignant cerebral edema following acute ischemic stroke"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0223-0597","authenticated-orcid":false,"given":"Yuanfeng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3660-1868","authenticated-orcid":false,"given":"Bozhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiexin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8287-7986","authenticated-orcid":false,"given":"Jianping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"6","key":"4684_CR1","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1161\/STROKEAHA.122.040008","volume":"54","author":"A de Havenon","year":"2023","unstructured":"de Havenon A, Zaidat OO, Amin-Hanjani S, et al. Large vessel occlusion stroke due to intracranial atherosclerotic disease: Identification, medical and interventional Treatment, and outcomes. Stroke Jun. 2023;54(6):1695\u2013705. https:\/\/doi.org\/10.1161\/STROKEAHA.122.040008.","journal-title":"Stroke Jun"},{"issue":"10","key":"4684_CR2","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1001\/jamaneurol.2019.2109","volume":"1","author":"A Sarraj","year":"2019","unstructured":"Sarraj A, Hassan AE, Savitz S, et al. Outcomes of endovascular thrombectomy vs medical management alone in patients with large ischemic cores: A secondary analysis of the optimizing patient\u2019s selection for endovascular treatment in acute ischemic stroke (SELECT) study. JAMA Neurol Oct. 2019;1(10):1147\u201356. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2109.","journal-title":"JAMA Neurol Oct"},{"issue":"9","key":"4684_CR3","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1161\/strokeaha.118.024766","volume":"50","author":"DS Liebeskind","year":"2019","unstructured":"Liebeskind DS, J\u00fcttler E, Shapovalov Y, Yegin A, Landen J, Jauch EC. Cerebral edema associated with large hemispheric infarction. Stroke. 2019;50(9):2619\u201325. https:\/\/doi.org\/10.1161\/strokeaha.118.024766.","journal-title":"Stroke"},{"issue":"10","key":"4684_CR4","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1136\/neurintsurg-2018-014650","volume":"11","author":"X Huang","year":"2019","unstructured":"Huang X, Yang Q, Shi X, et al. Predictors of malignant brain edema after mechanical thrombectomy for acute ischemic stroke. J Neurointerv Surg Oct. 2019;11(10):994\u20138. https:\/\/doi.org\/10.1136\/neurintsurg-2018-014650.","journal-title":"J Neurointerv Surg Oct"},{"issue":"1","key":"4684_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1227\/NEU.0000000000001735","volume":"1","author":"GJ Cannarsa","year":"2022","unstructured":"Cannarsa GJ, Wessell AP, Chryssikos T, et al. Initial stress hyperglycemia is associated with malignant cerebral Edema, Hemorrhage, and poor functional outcome after mechanical thrombectomy. Neurosurgery Jan. 2022;1(1):66\u201371. https:\/\/doi.org\/10.1227\/NEU.0000000000001735.","journal-title":"Neurosurgery Jan"},{"issue":"4","key":"4684_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2174\/1567202617666200517110509","volume":"17","author":"X Bai","year":"2020","unstructured":"Bai X, Wang C, Wang L, et al. Association between neutrophil to lymphocyte ratio and malignant brain edema in patients with large hemispheric infarction. Curr Neurovasc Res. 2020;17(4):429\u201336. https:\/\/doi.org\/10.2174\/1567202617666200517110509.","journal-title":"Curr Neurovasc Res"},{"issue":"1","key":"4684_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41598-018-19267-4","volume":"17","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Liu G, Wang Y, Su Y, Leak RK, Cao G. Procalcitonin as a biomarker for malignant cerebral edema in massive cerebral infarction. Sci Rep Jan. 2018;17(1):993. https:\/\/doi.org\/10.1038\/s41598-018-19267-4.","journal-title":"Sci Rep Jan"},{"issue":"1","key":"4684_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/23969873221145391","volume":"8","author":"T Honegger","year":"2023","unstructured":"Honegger T, Schweizer J, Bicvic A, et al. Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic stroke. Eur Stroke J Mar. 2023;8(1):309\u201319. https:\/\/doi.org\/10.1177\/23969873221145391.","journal-title":"Eur Stroke J Mar"},{"issue":"1","key":"4684_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000363619","volume":"38","author":"C MacCallum","year":"2014","unstructured":"MacCallum C, Churilov L, Mitchell P, Dowling R, Yan B. Low Alberta stroke program early CT score (ASPECTS) associated with malignant middle cerebral artery infarction. Cerebrovasc Dis. 2014;38(1):39\u201345. https:\/\/doi.org\/10.1159\/000363619.","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"4684_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12883-021-02456-6","volume":"9","author":"X Yi","year":"2021","unstructured":"Yi X, Zhou Q, Qing T, et al. 20-hydroxyeiscosatetraenoic acid May be as a predictor of malignant middle cerebral artery infarction in patients with massive middle cerebral artery infarction. BMC Neurol Nov. 2021;9(1):437. https:\/\/doi.org\/10.1186\/s12883-021-02456-6.","journal-title":"BMC Neurol Nov"},{"key":"4684_CR11","doi-asserted-by":"publisher","first-page":"101977","DOI":"10.1016\/j.eclinm.2023.101977","volume":"59","author":"S Wu","year":"2023","unstructured":"Wu S, Wang Y, Yuan R, et al. Predicting the emergence of malignant brain oedema in acute ischaemic stroke: a prospective multicentre study with development and validation of predictive modelling. EClinicalMedicine May. 2023;59:101977. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101977.","journal-title":"EClinicalMedicine May"},{"issue":"12","key":"4684_CR12","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1161\/STROKEAHA.118.022001","volume":"49","author":"S Wu","year":"2018","unstructured":"Wu S, Yuan R, Wang Y, et al. Early prediction of malignant brain edema after ischemic stroke. Stroke Dec. 2018;49(12):2918\u201327. https:\/\/doi.org\/10.1161\/STROKEAHA.118.022001.","journal-title":"Stroke Dec"},{"issue":"2","key":"4684_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.pmr.2016.01.003","volume":"27","author":"G Barkhoudarian","year":"2016","unstructured":"Barkhoudarian G, Hovda DA, Giza CC. The molecular pathophysiology of concussive brain Injury - an update. Phys Med Rehabil Clin N Am May. 2016;27(2):373\u201393. https:\/\/doi.org\/10.1016\/j.pmr.2016.01.003.","journal-title":"Phys Med Rehabil Clin N Am May"},{"issue":"8","key":"4684_CR14","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.bbi.2012.06.008","volume":"26","author":"A Kumar","year":"2012","unstructured":"Kumar A, Loane DJ. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav Immun Nov. 2012;26(8):1191\u2013201. https:\/\/doi.org\/10.1016\/j.bbi.2012.06.008.","journal-title":"Brain Behav Immun Nov"},{"issue":"8","key":"4684_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrd1157","volume":"2","author":"JK Nicholson","year":"2003","unstructured":"Nicholson JK, Wilson ID. Opinion: Understanding \u2018global\u2019 systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov Aug. 2003;2(8):668\u201376. https:\/\/doi.org\/10.1038\/nrd1157.","journal-title":"Nat Rev Drug Discov Aug"},{"issue":"7","key":"4684_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol Jul. 2016;17(7):451\u20139. https:\/\/doi.org\/10.1038\/nrm.2016.25.","journal-title":"Nat Rev Mol Cell Biol Jul"},{"key":"4684_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1146\/annurev.pharmtox.48.113006.094715","volume":"48","author":"R Kaddurah-Daouk","year":"2008","unstructured":"Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol. 2008;48:653\u201383. https:\/\/doi.org\/10.1146\/annurev.pharmtox.48.113006.094715.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"4684_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41582-020-0350-6","volume":"16","author":"J Montaner","year":"2020","unstructured":"Montaner J, Ramiro L, Simats A, et al. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke. Nat Rev Neurol May. 2020;16(5):247\u201364. https:\/\/doi.org\/10.1038\/s41582-020-0350-6.","journal-title":"Nat Rev Neurol May"},{"issue":"2","key":"4684_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/092986713804806621","volume":"20","author":"MS Monteiro","year":"2013","unstructured":"Monteiro MS, Carvalho M, Bastos ML, Guedes de Pinho P. Metabolomics analysis for biomarker discovery: advances and challenges. Curr Med Chem. 2013;20(2):257\u201371. https:\/\/doi.org\/10.2174\/092986713804806621.","journal-title":"Curr Med Chem"},{"issue":"4","key":"4684_CR20","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jprot.2011.10.027","volume":"75","author":"A Zhang","year":"2012","unstructured":"Zhang A, Sun H, Wang P, Han Y, Wang X. Recent and potential developments of biofluid analyses in metabolomics. J Proteomics Feb 2. 2012;75(4):1079\u201388. https:\/\/doi.org\/10.1016\/j.jprot.2011.10.027.","journal-title":"J Proteomics Feb 2"},{"issue":"1","key":"4684_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1212\/wnl.53.1.126","volume":"13","author":"HP Adams Jr","year":"1999","unstructured":"Adams HP Jr., Davis PH, Leira EC, et al. Baseline NIH stroke scale score strongly predicts outcome after stroke: A report of the trial of org 10172 in acute stroke treatment (TOAST). Neurology Jul. 1999;13(1):126\u201331. https:\/\/doi.org\/10.1212\/wnl.53.1.126.","journal-title":"Neurology Jul"},{"key":"4684_CR22","doi-asserted-by":"publisher","unstructured":"Heim C, Schoettker P, Spahn DR. [Glasgow Coma Scale in traumatic brain injury]. Anaesthesist. Dec 2004;53(12):1245-55; quiz 1256. Glasgow Coma Score fur den Patienten mit Schadel-Hirn-Trauma. https:\/\/doi.org\/10.1007\/s00101-004-0777-y.","DOI":"10.1007\/s00101-004-0777-y"},{"issue":"9","key":"4684_CR23","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1161\/01.str.0000027437.22450.bd","volume":"33","author":"JT Wilson","year":"2002","unstructured":"Wilson JT, Hareendran A, Grant M, et al. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin scale. Stroke Sep. 2002;33(9):2243\u20136. https:\/\/doi.org\/10.1161\/01.str.0000027437.22450.bd.","journal-title":"Stroke Sep"},{"issue":"9","key":"4684_CR24","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1161\/STROKEAHA.117.018223","volume":"48","author":"M Thoren","year":"2017","unstructured":"Thoren M, Azevedo E, Dawson J, et al. Predictors for cerebral edema in acute ischemic stroke treated with intravenous thrombolysis. Stroke Sep. 2017;48(9):2464\u201371. https:\/\/doi.org\/10.1161\/STROKEAHA.117.018223.","journal-title":"Stroke Sep"},{"issue":"3","key":"4684_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMcp1917030","volume":"16","author":"WJ Powers","year":"2020","unstructured":"Powers WJ. Acute ischemic stroke. N Engl J Med Jul. 2020;16(3):252\u201360. https:\/\/doi.org\/10.1056\/NEJMcp1917030.","journal-title":"N Engl J Med Jul"},{"key":"4684_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11306-016-1030-9","volume":"12","author":"R Di Guida","year":"2016","unstructured":"Di Guida R, Engel J, Allwood JW, et al. Non-targeted UHPLC-MS metabolomic data processing methods: a comparative investigation of normalisation, missing value imputation, transformation and scaling. Metabolomics. 2016;12:93. https:\/\/doi.org\/10.1007\/s11306-016-1030-9.","journal-title":"Metabolomics"},{"issue":"7","key":"4684_CR27","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","volume":"30","author":"WB Dunn","year":"2011","unstructured":"Dunn WB, Broadhurst D, Begley P, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc Jun. 2011;30(7):1060\u201383. https:\/\/doi.org\/10.1038\/nprot.2011.335.","journal-title":"Nat Protoc Jun"},{"key":"4684_CR28","doi-asserted-by":"publisher","unstructured":"Key A, Haiman Z, Palsson BO, D\u2019Alessandro A. Modeling red blood cell metabolism in the omics era. Metabolites Nov. 2023;11(11). https:\/\/doi.org\/10.3390\/metabo13111145.","DOI":"10.3390\/metabo13111145"},{"key":"4684_CR29","doi-asserted-by":"publisher","unstructured":"D\u2019Alessandro A, Anastasiadi AT, Tzounakas VL et al. Red Blood Cell Metabolism In Vivo and In Vitro. Metabolites. Jun 27. 2023;13(7) https:\/\/doi.org\/10.3390\/metabo13070793.","DOI":"10.3390\/metabo13070793"},{"issue":"2","key":"4684_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s12035-013-8487-6","volume":"48","author":"SD Skaper","year":"2013","unstructured":"Skaper SD, Facci L, Giusti P. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator. Mol Neurobiol Oct. 2013;48(2):340\u201352. https:\/\/doi.org\/10.1007\/s12035-013-8487-6.","journal-title":"Mol Neurobiol Oct"},{"issue":"2","key":"4684_CR31","doi-asserted-by":"publisher","first-page":"e00300","DOI":"10.1002\/prp2.300","volume":"5","author":"L Gabrielsson","year":"2017","unstructured":"Gabrielsson L, Gouveia-Figueira S, Haggstrom J, Alhouayek M, Fowler CJ. The anti-inflammatory compound palmitoylethanolamide inhibits prostaglandin and hydroxyeicosatetraenoic acid production by a macrophage cell line. Pharmacol Res Perspect Apr. 2017;5(2):e00300. https:\/\/doi.org\/10.1002\/prp2.300.","journal-title":"Pharmacol Res Perspect Apr"},{"issue":"31","key":"4684_CR32","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.2174\/1381612811319310009","volume":"19","author":"M Sabalza","year":"2013","unstructured":"Sabalza M, Vamvaka E, Christou P, Capell T. Seeds as a production system for molecular pharming applications: status and prospects. Curr Pharm Des. 2013;19(31):5543\u201352. https:\/\/doi.org\/10.2174\/1381612811319310009.","journal-title":"Curr Pharm Des"},{"issue":"8","key":"4684_CR33","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.bbi.2012.07.021","volume":"26","author":"A Ahmad","year":"2012","unstructured":"Ahmad A, Crupi R, Impellizzeri D, et al. Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice. Brain Behav Immun Nov. 2012;26(8):1310\u201321. https:\/\/doi.org\/10.1016\/j.bbi.2012.07.021.","journal-title":"Brain Behav Immun Nov"},{"key":"4684_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1476-511X-9-47","volume":"14","author":"M Naccarato","year":"2010","unstructured":"Naccarato M, Pizzuti D, Petrosino S, et al. Possible Anandamide and palmitoylethanolamide involvement in human stroke. Lipids Health Dis May. 2010;14:9:47. https:\/\/doi.org\/10.1186\/1476-511X-9-47.","journal-title":"Lipids Health Dis May"},{"issue":"10","key":"4684_CR35","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.drudis.2014.06.007","volume":"19","author":"M Alhouayek","year":"2014","unstructured":"Alhouayek M, Muccioli GG. Harnessing the anti-inflammatory potential of palmitoylethanolamide. Drug Discov Today Oct. 2014;19(10):1632\u20139. https:\/\/doi.org\/10.1016\/j.drudis.2014.06.007.","journal-title":"Drug Discov Today Oct"},{"issue":"11","key":"4684_CR36","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/ATVBAHA.118.311185","volume":"38","author":"P Rinne","year":"2018","unstructured":"Rinne P, Guillamat-Prats R, Rami M, et al. Palmitoylethanolamide promotes a proresolving macrophage phenotype and attenuates atherosclerotic plaque formation. Arterioscler Thromb Vasc Biol Nov. 2018;38(11):2562\u201375. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311185.","journal-title":"Arterioscler Thromb Vasc Biol Nov"},{"issue":"1","key":"4684_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5853\/jos.2018.03454","volume":"21","author":"E Sidorov","year":"2019","unstructured":"Sidorov E, Sanghera DK, Vanamala JKP. Biomarker for ischemic stroke using metabolome: A clinician perspective. J Stroke Jan. 2019;21(1):31\u201341. https:\/\/doi.org\/10.5853\/jos.2018.03454.","journal-title":"J Stroke Jan"},{"issue":"5","key":"4684_CR38","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.clnu.2017.07.005","volume":"37","author":"KJ Rudreshkumar","year":"2018","unstructured":"Rudreshkumar KJ, Majumdar V, Nagaraja D, Christopher R. Relevance of plasma levels of free homocysteine and methionine as risk predictors for ischemic stroke in the young. Clin Nutr Oct. 2018;37(5):1715\u201321. https:\/\/doi.org\/10.1016\/j.clnu.2017.07.005.","journal-title":"Clin Nutr Oct"},{"key":"4684_CR39","doi-asserted-by":"publisher","unstructured":"Madeo F, Eisenberg T, Pietrocola F, Kroemer G. Spermidine in health and disease. Science Jan. 2018;26(6374). https:\/\/doi.org\/10.1126\/science.aan2788.","DOI":"10.1126\/science.aan2788"},{"key":"4684_CR40","doi-asserted-by":"publisher","first-page":"843616","DOI":"10.3389\/fnut.2022.843616","volume":"9","author":"L Zheng","year":"2022","unstructured":"Zheng L, Xie Y, Sun Z, et al. Serum spermidine in relation to risk of stroke: A multilevel study. Front Nutr. 2022;9:843616. https:\/\/doi.org\/10.3389\/fnut.2022.843616.","journal-title":"Front Nutr"},{"issue":"6","key":"4684_CR41","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1523\/JNEUROSCI.4351-10.2011","volume":"9","author":"B Duan","year":"2011","unstructured":"Duan B, Wang YZ, Yang T, et al. Extracellular spermine exacerbates ischemic neuronal injury through sensitization of ASIC1a channels to extracellular acidosis. J Neurosci Feb. 2011;9(6):2101\u201312. https:\/\/doi.org\/10.1523\/JNEUROSCI.4351-10.2011.","journal-title":"J Neurosci Feb"},{"issue":"15","key":"4684_CR42","doi-asserted-by":"publisher","first-page":"e035837","DOI":"10.1161\/JAHA.124.035837","volume":"6","author":"P Yang","year":"2024","unstructured":"Yang P, Shi M, Jia Y, et al. Plasma polyamines and Short-Term adverse outcomes among patients with ischemic stroke: A prospective cohort study. J Am Heart Assoc. Aug 2024;6(15):e035837. https:\/\/doi.org\/10.1161\/JAHA.124.035837.","journal-title":"J Am Heart Assoc"},{"issue":"44","key":"4684_CR43","doi-asserted-by":"publisher","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","volume":"1","author":"Y Ou","year":"2016","unstructured":"Ou Y, Wang SJ, Li D, Chu B, Gu W. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci U S A Nov. 2016;1(44):E6806\u201312. https:\/\/doi.org\/10.1073\/pnas.1607152113.","journal-title":"Proc Natl Acad Sci U S A Nov"},{"issue":"1","key":"4684_CR44","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1038\/s41598-017-03909-0","volume":"15","author":"J Chen","year":"2017","unstructured":"Chen J, Hu R, Liao H, et al. A non-ionotropic activity of NMDA receptors contributes to glycine-induced neuroprotection in cerebral ischemia-reperfusion injury. Sci Rep Jun. 2017;15(1):3575. https:\/\/doi.org\/10.1038\/s41598-017-03909-0.","journal-title":"Sci Rep Jun"},{"key":"4684_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neulet.2017.01.039","volume":"6","author":"D Wang","year":"2017","unstructured":"Wang D, Kong J, Wu J, Wang X, Lai M. GC-MS-based metabolomics identifies an amino acid signature of acute ischemic stroke. Neurosci Lett Mar. 2017;6:642:7\u201313. https:\/\/doi.org\/10.1016\/j.neulet.2017.01.039.","journal-title":"Neurosci Lett Mar"},{"key":"4684_CR46","doi-asserted-by":"publisher","unstructured":"Lien LM, Chiou HY, Yeh HL, et al. Significant association between low mitochondrial DNA content in peripheral blood leukocytes and ischemic stroke. J Am Heart Assoc Nov. 2017;18(11). https:\/\/doi.org\/10.1161\/JAHA.117.006157.","DOI":"10.1161\/JAHA.117.006157"},{"issue":"4","key":"4684_CR47","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3945\/jn.114.201293","volume":"145","author":"C Nagata","year":"2015","unstructured":"Nagata C, Wada K, Tamura T, et al. Dietary intakes of glutamic acid and Glycine are associated with stroke mortality in Japanese adults. J Nutr Apr. 2015;145(4):720\u20138. https:\/\/doi.org\/10.3945\/jn.114.201293.","journal-title":"J Nutr Apr"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04684-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:04:43Z","timestamp":1772582683000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04684-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4684"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04684-0","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients\u2019 capacity to provide informed consent was assessed by the attending neurologist based on clinical status, Glasgow Coma Scale score, and the ability to understand and communicate. Patients deemed capable provided written informed consent themselves; otherwise, written informed consent was obtained from their legally authorized representatives. The study was approved by the Ethics Committee of the First Affiliated Hospital of Chengdu Medical College (Approval No. LXKY00006) and conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript is original, has not been published, and is not under consideration elsewhere. All authors have read and approved the final version and agree to its submission. All necessary permissions from the affiliated institutions have been obtained. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}